Myelopeptides and their therapeutic use

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 7/06 (2006.01) A61K 38/08 (2006.01) C07K 5/11 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2274731

A peptide comprising 4 to 10 amino acids including X1-Pro, Pro-X2 or X1-Pro- X2, wherein X1 and X2 are independently selected from Lys, Arg, His, Asp, Glu, Asn and Gln, and the other amino acids are independently selected from Gly, Ala, Val, Leu, Ile, Nle, Nva, Pro, Phe, Tyr, Trp, Cys, Met, Ser and Thr. Such peptides, including LVCYPQ, FRPRIMTP, VVYPD and VDPP, obtainable from porcine bone marrow cell culture, having immunostimulating and anti-viral properties.

La présente invention a trait à un peptide renfermant entre 4 et 10 acides aminés comprenant X?1¿-pro, Pro-X?2¿ ou X?1¿-pro-X ?2¿, où X?1¿ et X?2¿ sont sélectionnés indépendamment à partir de lys, Arg, His, Asp, Glu, Asn et Gln. Les autres acides aminés sont sélectionnés indépendamment à partir de Gly, Ala, Val, Leu, Ile, Nle, Nva, Pro, Phe, Tyr, Trp, Cys, Met, Ser et Thr. De tels peptides, y compris LVCYPQ, FRPRIMTP, VVYPD et VDPP, qu'on peut obtenir à partir d'une culture de cellules porcines médullaires, possèdent des propriétés immunostimulantes et antivirales.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Myelopeptides and their therapeutic use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Myelopeptides and their therapeutic use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Myelopeptides and their therapeutic use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1910748

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.